Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04743414 · ClinicalTrials.gov registry record · Phase 1
Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects
A Phase 1 study, sponsored by Concert Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT04743414 is a Phase 1 study that has completed, run by Concert Pharmaceuticals. The registered enrollment target is 22 participants.
The verdict
NCT04743414, a Phase 1 study, has completed, sponsored by Concert Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
This is a Phase 1 open-label study of the effect of itraconazole on the pharmacokinetics of CTP-543 in healthy subjects.
Interventions
- DRUG CTP-543
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2021-04-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04743414
The ClinicalTrials.gov registry entry for NCT04743414 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Concert Pharmaceuticals, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CTP-543 is the first listed.
NCT04743414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04743414 about?
NCT04743414 is a clinical study titled "Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects". This is a Phase 1 open-label study of the effect of itraconazole on the pharmacokinetics of CTP-543 in healthy subjects.
What is the current status of trial NCT04743414?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2021-03-02. Estimated completion is 2021-04-05.
What interventions are being tested in trial NCT04743414?
The interventions under investigation include: CTP-543 (DRUG).
Who is sponsoring clinical trial NCT04743414?
This trial is sponsored by Concert Pharmaceuticals, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.